Hormone therapy in transgender women may deteriorate cardiovascular health

Hormone treatment given to transgender patients transitioning from male to female may significantly increase their risk of stroke, a study inAnnals of Internal Medicine reports. Reuters
Source: Society for Endocrinology - Category: Endocrinology Source Type: news

Related Links:

(Natural News) The relationship between migraines and hormones is one that has led to many women receiving warnings against hormone therapy. Using oral contraceptives has long been believed to increase the risk of stroke among migraine sufferers. Yet according to a recent study from the Women’s Health Initiative (WHI), that may not be necessarily be...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
CONCLUSIONS: In this long-term follow-up study, taking hormones during menopause was not associated with overall mortality among middle-aged women. Investigating cause-specific mortality revealed significant albeit weak associations differential according to both causes of death and over time underlining the importance of carefully considering individual risks and duration of treatment when making decisions on hormone therapy. This article is protected by copyright. All rights reserved. PMID: 30106241 [PubMed - as supplied by publisher]
Source: BJOG : An International Journal of Obstetrics and Gynaecology - Category: OBGYN Authors: Tags: BJOG Source Type: research
Abstract This review examines the relationship between exogenous sex steroids and cardiovascular events and surrogate markers in trans (transgender) people. Data from trans populations is compared to data from postmenopausal women and hypogonadal men when appropriate. In an age-adjusted comparison with cisgender people, trans people appear to have an increased risk for myocardial infarction and death due to cardiovascular disease. It is uncertain whether hormone therapy in trans people affects their risk of stroke. In studies that followed trans people on hormone therapy, the rates of myocardial infarction and str...
Source: ENDOCR REV - Category: Endocrinology Authors: Tags: Rev Endocr Metab Disord Source Type: research
AbstractThis review examines the relationship between exogenous sex steroids and cardiovascular events and surrogate markers in trans (transgender) people. Data from trans populations is compared to data from postmenopausal women and hypogonadal men when appropriate. In an age-adjusted comparison with cisgender people, trans people appear to have an increased risk for myocardial infarction and death due to cardiovascular disease. It is uncertain whether hormone therapy in trans people affects their risk of stroke. In studies that followed trans people on hormone therapy, the rates of myocardial infarction and stroke were c...
Source: Reviews in Endocrine and Metabolic Disorders - Category: Endocrinology Source Type: research
Menopause is an important transition in the life of women. It has been estimated that by the year 2030, worldwide 1.2 billion women will be menopausal. The most bothersome symptoms of menopause are believed to be due to declines in estrogen levels in postmenopausal women. Thus, hormone therapy is an effective treatment option for menopausal women, although prolonged use of hormone therapy is associated with a slightly increased risk of breast cancer, thromboembolism, and stroke. A literature search for studies evaluating the effects of hormone therapy in menopausal women with asymptomatic fibroids demonstrated variable eff...
Source: Menopause - Category: OBGYN Tags: Personal Perspective Source Type: research
Researchers at Kaiser Permanente and Emory University studied 100,000 people for the first ever study on the risk of hormone therapy in transgender men and women.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
TUESDAY, July 10, 2018 -- Transwomen who undergo hormone therapy may face higher chances of blood clots, stroke and heart attack, a new study suggests. The term transwoman refers to a woman who is designated male at birth. Some undergo hormone...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Hormones given to people to align their sex with their gender pose a significant risk of serious blood clots and stroke among transgender women.
Source: PsycPORT.com - Category: Psychiatry Source Type: news
Conclusion: The patterns of increases in VTE and ischemic stroke rates among transfeminine persons are not consistent with those observed in cisgender women. These results may indicate the need for long-term vigilance in identifying vascular side effects of cross-sex estrogen. Primary Funding Source: Patient-Centered Outcomes Research Institute and Eunice Kennedy Shriver National Institute of Child Health and Human Development. PMID: 29987313 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Tags: Ann Intern Med Source Type: research
Researchers at Kaiser Permanente and Emory University studied 100,000 people for the first ever study on the risk of hormone therapy in transgender men and women.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Cardiology | Cardiovascular | Endocrinology | Heart | Hormonal Therapy | Hormones | Internal Medicine | Stroke | Study | Women